Efficacy and Safety of Dapagliflozin versus Liraglutide in Patients with Overweight or Obesity and Type 2 Diabetes Mellitus: A Randomised Controlled Clinical Trial in Tianjin, China
Objective. We aimed to clarify the efficacy of dapagliflozin versus liraglutide in patients with overweight or obesity and type 2 diabetes mellitus (T2DM) at the beginning of the coronavirus disease 2019 (COVID-19) pandemic. Methods. T2DM patients with overweight or obesity who visited the Metabolic...
Saved in:
Main Authors: | Hao Zhaohu, Huang Xiao, Shao Hailin, He Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2022/4126995 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide
by: Maria Voukali, et al.
Published: (2014-01-01) -
Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
by: Kimberley Doucette, et al.
Published: (2020-01-01) -
Thyroid Hormone Changes in the Northern Area of Tianjin during the COVID-19 Pandemic
by: Dong Weiwei, et al.
Published: (2022-01-01) -
Circulating Adipokines in Healthy versus Unhealthy Overweight and Obese Subjects
by: Assim A. Alfadda
Published: (2014-01-01) -
Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial)
by: Robert U Newton, et al.
Published: (2022-06-01)